StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

Adriamycin aglycone

HCID 72401
NotizenReaktionen
GrundinformationenNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
24385-10-2
Standard-SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O
InChIKey
IBZGBXXTIGCACK-CWKPULSASA-N
Summenformel
C21H18O9
Durchschnittliche Molmasse
414,4 g/mol
Monoisotopische Masse
414,09508215

Namen und Bezeichner

Bevorzugter Name
Adriamycin aglycone
IUPAC
(7S,9S)-6,7,9,11-tetrahydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Englischer Name
Doxorubicinone
Summenformel
C21H18O9
Molmasse
414.36

Namen und Synonyme

DoxorubicinoneAdriamycinone24385-10-2Adriamycin aglyconeDoxorubicin aglyconeX023T6C35L5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-DTXSID70875303(7S,9S)-9-glycoloyl-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinoneRefChem:109840DTXCID701772330(7S,9S)-6,7,9,11-tetrahydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Weitere Namen anzeigen
D2-N-Nitroso desmethyldoxycyclineadriamycinaglyconeEpirubicin aglyconEpirubicin aglyconeDoxorubicinone-13C-D3Epirubicin Hydrochloride Impurity A
(8S,10S)-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione(8S,10S)-6,8,10,11-tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dioneCCRIS 7633AdriamycinonUNII-X023T6C35L(8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydronaphthacene-5,12-dione (Doxorubicin Aglycone, Doxorubicinone)C21H18O9Doxorubicinone; (8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Doxorubicin Hydrochloride Impurity D; Epirubicin Hydrochloride Impurity A; Doxorubicin Impurity D; Epirubicin Impurity A

Datenbank-Bezeichner

CAS
24385-10-2
PubChem CID
72401
DTXSID
DTXSID70875303
ChEMBL
CHEMBL3544660
ChEBI
CHEBI:165223
UNII
X023T6C35L
EC Number
685-488-9
Nikkaji
J16.717G

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,6
Polarare Oberfläche (TPSA)
162 Ų
H-Brücken-Donoren
5
H-Brücken-Akzeptoren
9
Frei drehbare Bindungen
3
Schwere Atome
30
Formalladung
0
Komplexität
738

Physikochemische Eigenschaften

Schmelzpunkt
223 · 223-225°C
Siedepunkt
741.2 · 741.2±60.0 °C(Predicted)
Dichte
1.671 · 1.671±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Amber Vial, -20°C Freezer
Löslichkeit
Dioxane (Slightly), DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
7.45 · 7.45±0.60(Predicted)
Farbe
Red to Very Dark Red
Stabilität
Light Sensitive
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C21H18O9/c1-30-11-4-2-3-8-14(11)20(28)16-15(17(8)25)18(26)9-5-21(29,12(24)7-22)6-10(23)13(9)19(16)27/h2-4,10,22-23,26-27,29H,5-7H2,1H3/t10-,21-/m0/s1
InChIKey
IBZGBXXTIGCACK-CWKPULSASA-N
SMILES
C1(OC)=C2C(C(=O)C3=C(C2=O)C(O)=C2C(C[C@@](O)(C(CO)=O)C[C@@H]2O)=C3O)=CC=C1
CAS Datenbank
24385 · 24385-10-2

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral];H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal];H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation];H340 (100%): May cause genetic defects [Danger Germ cell mutagenicity];H350 (100%): May cause cancer [Danger Carcinogenicity];H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P318, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information · 1 Eintrag

5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazard Classes and CategoriesAcute Tox. 3 (100%);Acute Tox. 3 (100%);Acute Tox. 3 (100%);Muta. 1B (100%);Carc. 1B (100%);Repr. 1B (100%)

Regulatorische Informationen

Regulatory Information · 1 Eintrag

5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Sicherheitsdaten

wgk
WGK 3
hs_code
29147000
Speicherklasse
11 - Combustible Solids

Chemie und Industrie

Anwendungen · 2 Einträge

BeschreibungDoxorubicinone is a metabolite of the anthracycline antitumor antibiotic doxorubicin . Doxorubicinone inhibits mitochondrial succinoxidase from bovine heart and reduces the mitochondrial inner membrane potential in rat heart and liver mitochondria in a concentration-dependent manner. Doxorubicinone (40 μM) increases pentose phosphate pathway flux by 45% and reduces activity of glutathione peroxidase (GPx) and superoxide dismutase (SOD) by 17 and 60%, respectively, in human erythrocytes. It also induces cytotoxicity in patient-derived ovarian cancer colonies in a concentration-dependent manner.

VerwendenA metabolite of Doxorubicin (Dx).

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

(7S,9S)-9-(1,2-dihydroxyethyl)-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

Anbieter64 Anbieter

陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
Guangzhou Tosun Pharmaceutical Limited+86-18124244216 +86-18124244216 · [email protected]
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.+86-18603013401 · [email protected]
深圳市简一生物科技有限公司0755-84826604 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
上海柯维化学技术有限公司021-64609169 18901607656 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
Moxin Chemicals+86-17320513646 +86-17320513646 · [email protected]
深圳菲斯生物科技有限公司0755-83725681-603
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Clearsynth Labs Limited+91-22-26355700 · [email protected]
上海陶素生化科技有限公司021-33632979 · [email protected]
上海丽康新材料有限公司+86-16631818819 +86-17736933208 · [email protected]
PT CHEM GROUP LIMITED+86-85511178; +86-85511178 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
四川省维克奇生物科技有限公司028-81700200 18116577057 · [email protected]
深圳摩科生化科技有限公司18627923403 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
珠海安哲生物科技有限公司13169972583 · [email protected]
湖北源梦生物科技有限公司027-68897569 18120462897 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
河南誉康卓宁进出口有限公司13393721940 · [email protected]
R&D Scientific Inc.+1-2266000236 · [email protected]
苏州星北医药科技有限公司0512-0512-68437753 13861119411 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
湖北源梦生物科技有限公司027-68897569 18120462897 · [email protected]
风咏生物(AbMole)021-10000000 13000000000 · [email protected]
BOC Sciences16314854226 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
BOC Sciences[email protected]
湖北瑞诺医药科技有限公司13165688766 · [email protected]
广州佳途科技股份有限公司020-81960175-877 18933936954 · [email protected]
杭州洁汉化工有限公司+86-571-86217390; +8618058761490 · [email protected]
心邀(深圳)生物科技有限公司0755-89880280 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
广州市桐晖药业有限公司020-66392521-118 18922260391 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
深圳市恒丰万达医药科技有限公司13986652530 · [email protected]
Aladdin Scientific[email protected]

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 596933
HRID 596933als Produktuspto-grants-1977_03
Reaktionsgleichung von HRID 596935
HRID 596935als Produktuspto-grants-1977_03

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung